mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.06 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |